Advertisement

Mapping the Progress of Alzheimer’s and Parkinson’s Disease

  • Yoshikuni Mizuno
  • Abraham Fisher
  • Israel Hanin

Part of the Advances in Behavioral Biology book series (ABBI, volume 51)

Table of contents

  1. Front Matter
    Pages i-xxii
  2. Progress in Alzheimer’s Disease

    1. Etiology and Pathogenesis of Alzheimer’s Disease

      1. Dennis J. Selkoe, Weiming Xia, W. Taylor Kimberly, Konstantinos Vekrellis, Dominic Walsh, William Esler et al.
        Pages 1-6
      2. Nobuhisa Iwata, Takaomi C. Saido
        Pages 7-12
      3. Katsuhiko Yanagisawa, Katsumi Matsuzaki
        Pages 13-18
      4. Yoo-Hun Suh, Ji-Heui Seo, Yanji Xu, Chaejeong Heo, Najung Kim, Jun Ho Choi et al.
        Pages 19-25
      5. Alisa Tietz, Leah Oron, Eliezer Mazliah, Daniel M. Michaelson
        Pages 33-38
      6. Arun K. Raina, Catherine A. Rottkamp, Xiongwei Zhu, Osama Ogawa, Ayala Hochman, Shun Shimohama et al.
        Pages 49-57
    2. Familial Alzheimer’s Disease and Biology of Presenilins

      1. Takeshi Iwatsubo, Taisuke Tomita, Tomonari Watabiki, Rie Takikawa, Yuichi Morohashi, Nobumasa Takasugi
        Pages 65-71
      2. Edward H. Koo, Salvador Soriano, David E. Kang
        Pages 73-78
      3. Seong-Hun Kim, Sangram S. Sisodia
        Pages 85-90
      4. Harald Steiner, Magdalena Sastre, Gerd Multhaup, David B. Teplow, Christian Haass
        Pages 91-94
      5. Takashi Kudo, Taiichi Katayama, Kazunori Imaizumi, Yuka Yasuda, Misako Yatera, Masayasu Okochi et al.
        Pages 95-100
      6. Peter Kasa, Henrietta Papp, Magdolna Pakaski
        Pages 101-104
      7. Eun-Kyoung Choi, Joseph D. Buxbaum, Wilma Wasco
        Pages 105-110
    3. Animal Models of Alzheimer’s Disease

      1. Tomas Hökfelt, Margarita Diez, Tiejun Shi, Jari Koistinaho, Dora Games, Karen Kahn et al.
        Pages 117-120
      2. Kiyofumi Yamada, Manh Hung Tran, Hyoung-Chun Kim, Toshitaka Nabeshima
        Pages 121-126
      3. Michael C. Irizarry
        Pages 133-138
    4. Glycosaminoglycans (GAGs) in Alzheimer’s Disease

      1. U. Cornelli, I. Hanin, S. Lorens, J. Fareed, J. Lee, R. Mervis et al.
        Pages 145-155
      2. Qing Ma, Jawed Fareed, Bertalan Dudas, Umberto Cornelli, Stanley Lorens, John Lee et al.
        Pages 157-163
      3. M. Walzer, S. Lorens, M. Hejna, J. Fareed, R. Mervis, I. Hanin et al.
        Pages 165-170
      4. Israel Hanin, Bertalan Dudas, Ronald F. Mervis, Umberto Cornelli, John M. Lee, Stanley A. Lorens et al.
        Pages 171-176
    5. Clinical Evaluation of Alzheimer’s Disease

      1. Vesna Jelic, Bengt Winblad
        Pages 177-182
    6. Progress in the Treatment of Alzheimer’s Disease

      1. Avigdor Shafferman, Dov Barak, Arie Ordentlich, Naomi Ariel, Chanoch Kronman, Dana Kaplan et al.
        Pages 187-192
      2. Hachiro Sugimoto, Yoichi Iimura, Yoshiharu Yamanishi
        Pages 193-198
      3. Marta Weinstock, Tatyana Poltyrev, Corina Bejar, Yotam Sagi, Moussa B. H. Youdim
        Pages 199-204
    7. Novel Drug Treatment of Alzheimer’s Disease: Beyond Cholinesterase Inhibitors

      1. Abraham Fisher, Zipora Pittel, Rachel Haring, Rachel Brandeis, Nira Bar-Ner, Hagar Sonego et al.
        Pages 205-210
      2. D. K. Lahiri, T. Utsuki, K. T. Y. Shaw, Y.-W. Ge, K. Sambamurti, P. S. Eder et al.
        Pages 211-215
    8. New Treatment on the Horizon in Alzheimer’s Disease

      1. Kiminobu Sugaya, Tingyu Qu, Hojoong M. Kim, Christopher L. Brannen
        Pages 229-234
      2. Yoshihisa Kitamura, Jun-ichi Kakimura, Takashi Taniguchi, Shun Shimohama, Peter J. Gebicke-Haerter
        Pages 235-238
  3. Progress in Parkinson’s Disease

    1. Etiology and Pathogenesis

      1. Yoshikuni Mizuno, Nobutaka Hattori, Hideki Shimura, Tohru Kitada, Shin-ichiro Kubo, Mei Wang et al.
        Pages 239-244
      2. Kin-Lun Tsang, Zhe-Hui Feng, Hong Jiang, Shu-Leong Ho, David B. Ramsden
        Pages 251-257
      3. Toshiharu Nagatsu, Makio Mogi, Hiroshi Ichinose, Akifumi Togari
        Pages 265-270
      4. Todd B. Sherer, Ranjita Betarbet, J. Timothy Greenamyre
        Pages 271-276
      5. Wakako Maruyama, Takako Yamada, Yukihiko Washimi, Teruhiko Kachi, Nobuo Yanagisawa, Fujiko Ando et al.
        Pages 277-280
    2. Familial Parkinson’s Disease

      1. Katrina Gwinn-Hardy, Melissa Hanson, Zbigniew Wszolek, Amanda Adam, Andrew Singleton, Charles H. Adler et al.
        Pages 281-284
      2. Bülent Elibol, Tomonori Kobayashi, F. Belgin Ataç, Nobutaka Hattori, Gürdal Şahin, Günfer Gürer et al.
        Pages 285-290
      3. Nobutaka Hattori, Shuichi Asakawa, Hideki Shimura, Shin-ichiro Kubo, Kenichi Sato, Toshiaki Kitami et al.
        Pages 291-296

About this book

Introduction

1h The 5 International Conference on the Progress in Alzheimer's Disease and Parkinson's 51 1 Disease took place from March 31 to April 5 \ 2001 in Kroto, Japan. This international 1 conference was organized as a joint Congress with the 9 International Catecholamine Symposium. A total of 1258 clinicians and researchers participated in this joint congress 1h from 38 countries in the world. This book represents the proceedings of the 5 Conference on Alzheimer's and Parkinson's disease. The International Conference on the Progress in Alzheimer's and Parkinson's disease was first launched by Professor Abraham Fisher of Israel and Professor Israel Hanin of USA. The first conference was held in Eilat, Israel in 1985. The second conference was organized in Kyoto, Japan in 1989; the third one in Chicago, USA, in 1993, and the fourth one in Eilat, Israel in 1997. The International Catecholamine Symposium (ICS) is an international meeting devoted to the development of basic as well as clinical research on catecholamines. The first Catecholamine Symposium was held in Bethesda, USA in 1958. Since then this symposium has occurred every 5 years. Professor Toshiharu Nagatsu was appointed as 1h the president of the 9 International Catecholamine Symposium, which was to be held in 200 I also in Japan. Therefore, we decided to organize a joint congress of the two meetings, because there is much overlap in research between Alzheimer's disease, Parkinson's disease, and catecholamines. We thank Professor Nagatsu very much for agreeing to organizing this joint congress.

Keywords

Alzheimer Parkinson dementia depression dopamine

Editors and affiliations

  • Yoshikuni Mizuno
    • 1
  • Abraham Fisher
    • 2
  • Israel Hanin
    • 3
  1. 1.Juntendo University School of MedicineTokyoJapan
  2. 2.Israel Institute for Biological ResearchNess-ZionaIsrael
  3. 3.Stritch School of MedicineLoyola University ChicagoMaywoodUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-0-306-47593-1
  • Copyright Information Springer-Verlag US 2002
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4757-0973-5
  • Online ISBN 978-0-306-47593-1
  • Series Print ISSN 0099-6246
  • Buy this book on publisher's site